Nextuple Inc., a leading provider of innovative supply chain solutions, is proud to announce the launch of OnePint.ai, a new software company dedicated ...

Highlights: Extensive Soil Sampling Program on the Company's 100%-owned Detour project has successfully identified strong ...

Shanghai-based biotech firm Hexaell Biotech has secured 200 million renminbi ($31 million) in a series B+ funding round. The ...

Q32 Bio (Nasdaq: QTTB) has announced a corporate restructuring, shifting its focus entirely to the development of its lead ...

Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

Cohen & Steers, Inc. today reported preliminary assets under management of $86.4 billion as of January 31, 2025, an increase of $598 million from assets under management of $85.8 billion at December ...

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...

China hits back with export controls, Canada and Mexico remain under threat. USPS closes then reopens "de minimis" small ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...

The US Postal Service says it has temporarily suspended the acceptance of incoming international parcels from China and Hong ...

NEW YORK - Indaptus Therapeutics, Inc. (NASDAQ:INDP), a clinical-stage biotechnology company with a market capitalization of approximately $13 million, has received authorization from Health Canada to ...